Cargando…
Coptidis Rhizoma Suppresses Metastatic Behavior by Inhibiting TGF-β-Mediated Epithelial-Mesenchymal Transition in 5-FU-Resistant HCT116 Cells
Colorectal cancer (CRC) is the second most lethal malignancy worldwide. The high mortality rate of CRC is largely due to cancer metastasis. Recently, suppressing epithelial-to-mesenchymal transition (EMT) has been considered a promising strategy for treating metastatic cancer, especially drug-resist...
Autores principales: | Kang, Yong-Hwi, Wang, Jing-Hua, Lee, Jin-Seok, Lee, Nam-Hun, Son, Chang-Gue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234293/ https://www.ncbi.nlm.nih.gov/pubmed/35770076 http://dx.doi.org/10.3389/fphar.2022.909331 |
Ejemplares similares
-
Coptidis Rhizoma Extract Reverses 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells via Modulation of Thymidylate Synthase
por: Kang, Yong-Hwi, et al.
Publicado: (2021) -
Coptisine from Rhizoma Coptidis Suppresses HCT-116 Cells-related Tumor Growth in vitro and in vivo
por: Huang, Tao, et al.
Publicado: (2017) -
Rhizoma Coptidis: A Potential Cardiovascular Protective Agent
por: Tan, Hui-Li, et al.
Publicado: (2016) -
Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: He, Luying, et al.
Publicado: (2022) -
Erratum: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: Frontiers Production Office,
Publicado: (2022)